CONGENITAL ADRENAL HYPERPLASIA (CAH)
Clinical trials for CONGENITAL ADRENAL HYPERPLASIA (CAH) explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL ADRENAL HYPERPLASIA (CAH) trials appear
Sign up with your email to follow new studies for CONGENITAL ADRENAL HYPERPLASIA (CAH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Landmark study tracks 3,000 people to unravel mysteries of hormone disorders
Knowledge-focused Recruiting nowThis study aims to gather detailed information over time from people with genetic conditions that cause the body to produce too many male-like hormones (androgens). It will follow up to 3,000 participants, including children and adults, to better understand how these conditions a…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA (CAH)
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC
-
Syndromes with neonatal salt loss: not only congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OH-ISC)
Recruiting nowNeonatal salt loss can be caused not only by infections but also by rare endocrine disorders that resemble 21-hydroxylase deficiency but are not detected by neonatal screening. This study examines how often these conditions occur and describes their main clinical, genetic, and tr…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA (CAH)
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Last updated Mar 23, 2026 15:14 UTC